Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
Clinical trial NCT00147160 · COMPLETED
Trial details
- NCT number
- NCT00147160
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2006-07-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.